Kimya Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2019
- Revenue 9.00%
(FY 2017)
- Profit -35.68%
(FY 2017)
- Ebitda -28.67%
(FY 2017)
- Net Worth 19.67%
(FY 2017)
- Total Assets 10.35%
(FY 2017)
About Kimya Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vinay Nikam and Suvarna Nikam serve as directors at the Company.
- CIN/LLPIN
U01119PN2010PTC137238
- Company No.
137238
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2010
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kimya Biotech Private Limited offer?
Kimya Biotech Private Limited offers a wide range of products and services, including Flowering Plant, Carnation Plants, Gerbera Daisy Plant.
Who are the key members and board of directors at Kimya Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Nikam  | Managing Director | 30-Aug-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suvarna Nikam | Director | 30-Aug-2010 | Current |
Financial Performance of Kimya Biotech.
Kimya Biotech Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 9% increase. The company also saw a substantial fall in profitability, with a 35.68% decrease in profit. The company's net worth Soared by an impressive increase of 19.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kimya Biotech?
In 2017, Kimya Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kimya Biotech?
Unlock and access historical data on people associated with Kimya Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kimya Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kimya Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
